Screener
Ionis Pharmaceuticals IONS Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Collaborative agreement revenue | 133,137 | 336,921 | 253,797 | 381,951 |
| WAINUA joint development revenue | 16,189 | 12,372 | 33,811 | 22,785 |
| Total research and development revenue | 149,326 | 349,293 | 287,608 | 404,736 |
| Total revenue | 267,949 | 452,049 | 514,042 | 583,660 |
| Expenses: | ||||
| Cost of sales | 2,739 | 4,151 | 5,721 | 5,614 |
| Research, development and patent | 217,107 | 217,460 | 427,280 | 418,219 |
| Selling, general and administrative | 150,396 | 90,622 | 300,755 | 166,872 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's total revenue?
- Ionis Pharmaceuticals (IONS) reported total revenue of $267.95M in Q2 2026.
- How has Ionis Pharmaceuticals's total revenue changed year-over-year?
- Ionis Pharmaceuticals's total revenue decreased by 40.7% year-over-year, from $452.05M to $267.95M.
- What is the long-term trend for Ionis Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's total revenue has grown at a 3.9% compound annual growth rate (CAGR), from $810.46M to $943.71M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Ionis Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude